|
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Cervical cancer |
Conflicting classifications of pathogenicity |
rs146341788 |
RCV005905857 |
| Gastric cancer |
Benign; Likely benign; Conflicting classifications of pathogenicity |
rs61744790, rs146341788 |
RCV005906041 RCV005905858 |
| Hepatocellular carcinoma |
Conflicting classifications of pathogenicity |
rs146341788 |
RCV005905856 |
| Malignant tumor of urinary bladder |
Conflicting classifications of pathogenicity |
rs146341788 |
RCV005905855 |
| Popliteal pterygium syndrome |
Uncertain significance; Benign |
rs886057083, rs34075882, rs774016517 |
RCV000311475 RCV000314725 RCV000288676 |
| RIPK4-related disorder |
Benign; Likely benign; Uncertain significance; Conflicting classifications of pathogenicity |
rs55812846, rs35537517, rs2517319088, rs563351959, rs2146046679, rs151032253, rs146788763, rs147543398, rs150110999, rs143972232, rs147337665, rs145132650, rs1356031463, rs61740535, rs55645753, rs148947402, rs139503982, rs201024640, rs61739694, rs55798804, rs150704061, rs149475741, rs147930789, rs142879262, rs200420912, rs150480670 View all (11 more) |
RCV003937536 RCV003919909 RCV003402104 RCV003896958 RCV003894597 RCV003906941 RCV003901603 RCV003943951 RCV003963953 RCV003917213 RCV003937273 RCV003961397 RCV003956994 RCV003957238 RCV003912430 RCV003922484 RCV003932359 RCV003910324 RCV003897771 RCV003950178 RCV003932360 RCV003960865 RCV003926211 RCV003958382 RCV004753110 RCV003970503 RCV003906256 |
| Uterine corpus endometrial carcinoma |
Benign |
rs115041500 |
RCV005913868 |
|
| Disease Name |
Relationship Type |
References |
| Adenocarcinoma |
Associate |
28574510 |
| Adenocarcinoma of Lung |
Associate |
28574510, 35907206 |
| Carcinogenesis |
Associate |
35186499 |
| Carcinoma Squamous Cell |
Associate |
26148476, 35186499 |
| Down Syndrome |
Associate |
23783273 |
| Epidermal Cyst |
Associate |
25246526 |
| Haspeslagh Fryns Muelenaere syndrome |
Associate |
25691407 |
| Hay Wells syndrome |
Associate |
29523099 |
| Heart Defects Congenital |
Associate |
23783273 |
| Immune System Diseases |
Associate |
29523099 |
| Immunologic Deficiency Syndromes |
Associate |
29523099 |
| Inflammation |
Associate |
24519546, 35186499 |
| Leukemia |
Associate |
21044360 |
| Lung Neoplasms |
Inhibit |
28574510 |
| Lymphatic Metastasis |
Stimulate |
27697098 |
| Melanoma |
Associate |
39766280 |
| Neoplasm Metastasis |
Associate |
32016450, 34124253 |
| Neoplasms |
Associate |
26148476, 28574510, 35186499, 35310605, 38179758, 39766280 |
| Neoplasms |
Stimulate |
27697098, 32016450 |
| Neoplasms |
Inhibit |
28574510 |
| Osteoarthritis |
Associate |
29257245 |
| Ovarian Neoplasms |
Associate |
33487072, 33855091, 34124253, 35310605, 38179758 |
| Pancreatic Neoplasms |
Associate |
16036106 |
| Popliteal Pterygium Syndrome |
Associate |
25246526, 25691407 |
| Popliteal Pterygium Syndrome Lethal Type |
Associate |
25246526, 25691407 |
| Squamous Cell Carcinoma of Head and Neck |
Associate |
24519546 |
| Squamous Intraepithelial Lesions |
Stimulate |
26148476 |
| Tongue Neoplasms |
Inhibit |
24519546 |
| Urinary Bladder Neoplasms |
Associate |
29867225 |
| Uterine Cervical Neoplasms |
Associate |
26148476, 27697098 |
| Uterine Cervicitis |
Stimulate |
26148476 |
|